Chikungunya News and Research

RSS

Scientists detect replication-competent Oropouche virus in semen of traveler, sparking transmission fears

Researchers confirmed the presence of replication-competent Oropouche virus in semen, raising concerns about potential sexual transmission following a traveler's infection.

9 Oct 2024

Oropouche virus spreads in South America as scientists warn of potential outbreaks in the U.S.

Researchers review the reemergence and range expansion of Oropouche virus in South America, highlighting risks of spread to the U.S. and need for improved diagnostic tests. Over 9,000 cases and two deaths were reported in 2024.

4 Oct 2024

WHO unveils comprehensive strategy to combat dengue and Aedes-borne arboviruses

Today, the World Health Organization (WHO) launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP) to tackle dengue and other Aedes-borne arboviruses.

3 Oct 2024

New research network focuses on high-priority viruses

The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines and monoclonal antibodies. Currently, many of the diseases caused by these pathogens have no available vaccines or therapeutics, and investing in this research is key to preparing for potential public health crises-;both in the United States and around the world. NIH's National Institute of Allergy and Infectious Diseases (NIAID) expects to commit approximately $100 million per year to fund the program, pending the availability of funds.

14 Sep 2024

CDC identifies new Oropouche virus cases in U.S. travelers, raising public health concerns

The CDC reports 21 new cases of Oropouche virus among U.S. travelers from Brazil and Cuba, highlighting potential health risks and the need for vigilant monitoring and preventive measures.

29 Aug 2024

Olympic games could fuel spread of tropical diseases, warn health experts

Mosquito-borne diseases such as dengue, Zika, and chikungunya could spread via the Olympics to countries where they are not normally prevalent, warn global health experts, as authorities step up disease monitoring in the French capital.

7 Aug 2024

World's first deaths from Oropouche fever recorded in Brazil

The world's first deaths have been recorded from Oropouche fever, caused by a mosquito-borne virus that has spread silently from the Brazilian Amazon rainforest, raising alarm among scientists.

2 Aug 2024

New method can rapidly determine virus infectivity

A new method that can rapidly determine whether a virus is infectious or non-infectious could revolutionize the response to future pandemics.

23 Jul 2024

Tracking arboviruses by nanopore sequencing of mosquitoes

The technology used to sequence SARS-CoV-2 at record speed early in the COVID-19 pandemic has been successfully tested as a technique to monitor arboviruses and diseases transmitted mainly by mosquitoes.

17 Apr 2024

Redefining tuberculosis classification to enhance early detection and treatment

A new way to classify tuberculosis (TB) that aims to improve focus on the early stages of the disease has been launched by an international team including researchers from the London School of Hygiene and Tropical Medicine (LSHTM).

26 Mar 2024

How is climate change influencing the spread of vector-borne diseases?

The impact of climate change, weather, and other anthropogenic factors on vector-borne illness spread globally.

18 Mar 2024

New study highlights the urgent need for typhoid vaccination in sub-Saharan Africa

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health.

12 Mar 2024

Understanding how chikungunya virus affects the brain and body

The chikungunya virus, transmitted by Aedes aegypti and Aedes albopictus mosquitoes and responsible for more than 900 deaths in Brazil since it arrived around ten years ago, is capable of spreading through the blood, reaching multiple organs and crossing the blood-brain barrier, which protects the central nervous system.

12 Mar 2024

UK Aid awards funding to Oxford Vaccine Group for research into prevention of five epidemic threats

Oxford Vaccine Group (OVG), which led the rapid clinical development of the Oxford vaccine in COVID-19 in the pandemic, has been awarded a total of £7,788,783 by UK Aid for research into the prevention of five dangerous diseases with epidemic or pandemic potential.

13 Dec 2023

Pediatric viral threats surge in the 21st century: A call for One Health approach

Scoping review in "Pediatric Research" examines the rise of pediatric viral diseases in the 21st century and underscores the importance of a One Health approach, integrating human, animal, and ecosystem health, to combat these emerging and re-emerging infectious threats effectively.

9 Nov 2023

Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Bio Farma, a biotechnology company based in West Java, Indonesia, announced today that Bio Farma's Bio-TCV typhoid conjugate vaccine (TCV) was licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.

9 Nov 2023

CEPI and University of Oxford launch new project to initiate vaccine development against Junín virus

The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford today announced the launch of a new project to initiate early development of prototype vaccines against the Junín virus, selected as an exemplar of the Arenavirus family which is responsible for multiple deadly hemorrhagic fevers with epidemic and pandemic potential.

6 Nov 2023

Virginia Tech researchers develop new drug design framework to fight COVID-19

As the COVID-19 pandemic scattered and isolated people, researchers across Virginia Tech connected for a data-driven collaboration seeking improved drugs to fight the disease and potentially many other illnesses.

19 Oct 2023

Discovery lead to better methods for reducing mosquito-to-human transmission of deadly viruses

Researchers from the Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health have made an important finding about Aedes aegypti mosquitoes-;one that could one day lead to better methods for reducing the mosquito-to-human transmission of dengue, yellow fever, Zika, and other harmful and sometimes deadly viruses.

22 Sep 2023

Doctors advocate fresh efforts to combat Chagas disease, a silent killer

When Maira Gutiérrez was diagnosed with Chagas disease in 1997, neither she nor her primary care physician had even heard of the malady. She discovered her illness only by chance, after participating in a Red Cross blood drive organized by her employer, Universal Studios.

22 Aug 2023